PAHC | tickerfilter.com

Fundamental analysis

60%

Profitability 51%

Dept financing 50%

Liquidity 68%

Performance 70%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

2.28%

1 Month

-13.72%

3 Months

-15.84%

6 Months

-21.57%

1 Year

9.83%

2 Year

16.13%

Key data

Stock price

$18.43

P/E Ratio

44.03

DAY RANGE

$18.01 - $18.46

EPS

$0.45

52 WEEK RANGE

$16.06 - $26.55

52 WEEK CHANGE

$10.36

MARKET CAP

850.576 M

YIELD

2.29%

SHARES OUTSTANDING

20.338 M

DIVIDEND

$0.12

EX-DIVIDEND DATE

03-05-2025

NEXT EARNINGS DATE

05-07-2025

BETA

1.14

PUBLIC FLOAT

AVERAGE 10 VOLUME

$172,701

AVERAGE 30 VOLUME

$222,156

Company detail

CEO: Jack C. Bendheim
Region: US
Website: pahc.com
Employees: 1,860
IPO year: 2014

Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases.

PAHC - PHIBRO ANIMAL HEALTH CORP